Patents Assigned to Gilead Scineces, Inc.
  • Fused heterocyclic compounds as ion channel modulators
    Patent number: 9416115
    Abstract: The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein X, Y, Z, R2, R3, R4, p and q are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: August 16, 2016
    Assignee: Gilead Scineces, Inc.
    Inventors: Michael Graupe, Yafan Lu, Jeff A. Zablocki